All products / DC26039
CAT. NO. DC26039
ZLD1039
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $900 USDRequest a quote / confirm availability → |
| 250 mg | $1,500 USDRequest a quote / confirm availability → |
| 1 g | $2,800 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
ZLD1039 is a novel, orally active EZH2 inhibitor demonstrating high selectivity and potency. It effectively suppresses PRC2 enzymatic activity across wild-type EZH2 (IC50 = 5.6 nM) and mutant forms (Y641F: 15 nM; A677G: 4.0 nM), while exhibiting significant anti-tumor and anti-metastatic effects in breast cancer models.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC26039 |
|---|---|
| Product name | ZLD1039 |
| CAS | 1826865-46-6 |
| Molecular formula | C36H48N6O3 |
| Molecular weight | 612.8047 |
| Purity | >98% |
| SMILES | CCN(c1cc(-c2ccc(N3CCN(C)CC3)nc2)cc(C(=O)NCc2c3c(c(C)[nH]c2=O)CCCC3)c1C)C1CCOCC1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — ZLD1039 (DC26039)